#pharmacology #medicine To view or add a comment, sign in A groundbreaking finding from Duke University School of Medicine is changing our understanding of blood sugar regulation
Michelotti GA, Machado MV, Diehl AM
Potential for Broader Indications Given that obesity is linked with numerous comorbidities, CT-388 could have a range of potential future indications beyond obesity and T2D, such as nonalcoholic steatohepatitis (NASH), cardiovascular diseases (CVD), heart failure, osteoarthritis, sleep apnea, and chronic kidney disease (CKD)
If you develop a side effect with Repatha and want to tell the FDA about it, visit MedWatch or call 800-FDA-1088
Both options require a prescription and medical supervision, and when sourced from regulated pharmacies, they use the same active ingredients to target the body's hunger and insulin pathways